Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Using neurohormones to control keratin can lead to new skin disease treatments.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Targeting NETs may help reduce fibrosis in Crohn's disease.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Cyclosporin A promotes hair cell growth and affects protein kinase C levels.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Keratin protein production in cells is controlled by a complex system that changes with cell type, health, and conditions like injury or cancer.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

HAIR & SCALP COMPLEX may help treat hair loss by stimulating hair growth and restarting the hair cycle.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

A man lost all his hair as a rare side effect after hepatitis C treatment.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Stress and emotional factors can worsen skin conditions by affecting the immune system.